# Tandem Diabetes Care

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/tandem-diabetes-care
Canonical HTML page: https://getbiobrief.com/entity/tandem-diabetes-care

## Timeline

- **2026-03-06**: IPO Pricing — MiniMed prices 28 million shares at $20.00 per share, raising $560 million.
- **2026-03-04**: Analyst Debate — Market analysts debate the valuation of the diabetes unit amid competitive pressures.
- **2026-02-24**: Initial Filing — Medtronic's diabetes unit MiniMed seeks up to $784 million in U.S. IPO.

## Recent coverage (1 stories)

### Medtronic’s MiniMed Prices IPO at $20 Per Share, Raising $560 Million
2026-03-06 03:34:10 · Sentiment: Neutral · Impact: 6/10 · Sources: 2

Medtronic’s diabetes subsidiary, MiniMed Group Inc., has priced its initial public offering at $20.00 per share, successfully raising $560 million. The offering of 28 million shares comes in below initial valuation targets but marks a significant strategic pivot for parent company Medtronic plc.
Full story: https://getbiobrief.com/story/medtronic-minimed-ipo-pricing-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.